John Overdeck’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

John Overdeck’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-87,598	Closed	-$879K	–	3494
2023 Q4	$879K	Buy	87,598 +54,795	+167%	+$249K	﹤0.01%	2154
2023 Q3	$94.5K	Sell	32,803 -19,109	-37%	-$69.9K	﹤0.01%	2752
2023 Q2	$198K	Buy	51,912 +19,811	+62%	+$55.5K	﹤0.01%	2647
2023 Q1	$59.7K	Buy	+32,101	New	+$67.1K	﹤0.01%	2726
2021 Q2	–	Sell	-13,174	Closed	-$203K	–	4699
2021 Q1	$203K	Buy	+13,174	New	+$311K	﹤0.01%	3622

John Overdeck's GRCL Position: Q1 2024 in Review

John Overdeck sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 87,598 shares — an estimated $879K sold.

John Overdeck first reported a position in GRCL in Q1 2021 and held it in 5 quarters. The position peaked at $879K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

John Overdeck reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
John Overdeck sold 87,598 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $879K.
John Overdeck first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 5 quarters.
John Overdeck's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $879K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.